1. 2035 Diffusion-weighted magnetic resonance imaging for the prediction of the tumor response to neoadjuvant chemoradiotherapy using irinotecan plus S-1 for rectal cancer. (September 2015) Authors: Doi, H.; Beppu, N.; Kato, T.; Tanooka, M.; Kengo, K.; Tarutani, K.; Suzuki, H.; Odawara, S.; Niwa, Y.; Takada, Y.; Fujiwara, M.; Noda, M.; Tomita, N.; Kamikonya, N.; Hirota, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 608 Polaprezinc protects normal intestine and skin from radiation-induced damages in mice. (September 2015) Authors: Doi, H.; Odawara, S.; Shikata, T.; Tarutani, K.; Kosaka, K.; Suzuki, H.; Niwa, Y.; Tsujimura, T.; Kamikonya, N.; Hirota, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 634 Correlation analysis between pre-treatment verification precision and plan complexity or machine parameters using log files for VMAT delivery. (September 2015) Authors: Kosaka, K.; Tanooka, M.; Inoue, H.; Tarutani, K.; Fujiwara, M.; Niwa, Y.; Takada, Y.; Doi, H.; Odawara, S.; Suzuki, H.; Kamikonya, N.; Hirota, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 675PInvolvement of the immunoregulator MZB1 in progression of gastric cancer. (18th September 2017) Authors: Tanaka, Y.; Kanda, M.; Tanaka, C.; Kobayashi, D.; Tanaka, H.; Takami, H.; Hayashi, M.; Iwata, N.; Niwa, Y.; Yamada, S.; Nakayama, G.; Sugimoto, H.; Koike, M.; Fujiwara, M.; Kodera, Y. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Case of Hilar Cholangiocarcinoma Undergoing Curative Resection after Approximately One Year of Multidisciplinary Therapy. (2021) Authors: Hamano, M.; Katagiri, S.; Oota, M.; Onizawa, S.; Niwa, Y.; Sugishita, T.; Araida, T.; Yamamoto, M. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus. Issue 6 (1st September 2016) Authors: Oya, H.; Kanda, M.; Koike, M.; Iwata, N.; Niwa, Y.; Shimizu, D.; Takami, H.; Sueoka, S.; Hashimoto, R.; Ezaka, K.; Nomoto, S.; Yamada, S.; Fujii, T.; Nakayama, G.; Sugimoto, H.; Fujiwara, M.; Kodera, Y. Journal: Diseases of the esophagus Issue: Volume 29:Issue 6(2016) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Detection of serum melanoma‐associated antigen D4 in patients with squamous cell carcinoma of the esophagus. Issue 6 (8th May 2015) Authors: Oya, H.; Kanda, M.; Koike, M.; Iwata, N.; Niwa, Y.; Shimizu, D.; Takami, H.; Sueoka, S.; Hashimoto, R.; Ezaka, K.; Nomoto, S.; Yamada, S.; Fujii, T.; Nakayama, G.; Sugimoto, H.; Fujiwara, M.; Kodera, Y. Journal: Diseases of the esophagus Issue: Volume 29:Issue 6(2016) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EP-1527 Proton therapy for prostate ca: Comparison of toxicity between mod-hypo and conventional fraction. (April 2019) Authors: Waki, T.; Tominaga, Y.; Niwa, Y.; Ihara, H.; Jin, D.; Sugiyama, S.; Kawabata, T.; Katsui, K.; Fujishima, M.; Kanazawa, S. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EP-1568: Results of proton therapy for castration resistant prostate cancer. (April 2018) Authors: Takagi, M.; Demizu, Y.; Fuwa, N.; Terashima, K.; Fujii, O.; Jin, D.; Niwa, Y.; Hareyama, M.; Okimoto, T. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EP-1571: Is Neoadjuvant ADT Necessary for Intermediate-Risk Prostate Cancer Treated with Proton Therapy?. (April 2018) Authors: Takagi, M.; Demizu, Y.; Fuwa, N.; Sulaiman, N.S.; Terashima, K.; Fujii, O.; Jin, D.; Nagano, F.; Waki, T.; Mima, M.; Niwa, Y.; Katsui, K.; Murakami, M.; Okimoto, T. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗